Melissa M. Tomkiel
CIK 1859484 · Co-CEO and General Counsel · last filed 2026-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.50M
Companies
3
Total Filings
60
Lifetime Open-Market Net
-$2.54M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRTA | Co-CEO and General Counsel | 1,892,774 | $5.02 | $9.50M | -$174.5K | 2 | 2026-06-18 |
| Strata Critical Medical, Inc. (SRTAW) Delisted | Co-CEO and General Counsel | 2,244,254 | $0.00 | $1.3K | $0 | 9 | 2026-04-27 |
| Strata Critical Medical, Inc. (BLDEW) Delisted | President and General Counsel | 1,169,334 | $0.18 | $209.8K | -$2.37M | 39 | 2025-08-07 |
Recent Filings · Page 5 of 6
60 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-28 | Strata Critical Medical, Inc. (BLDEW) Delisted | Exer (M) | +13,516 | $2.4K | EDGAR |
| 2023-07-10 | Strata Critical Medical, Inc. (BLDEW) Delisted | Sell (S) | −91,080 | -$348.3K | EDGAR |
| 2023-07-06 | SRTA | Notice (144) | −108,187 | -$345.3K | EDGAR |
| 2023-04-11 | Strata Critical Medical, Inc. (BLDEW) Delisted | Sell (S) | −39,951 | -$115.7K | EDGAR |
| 2023-03-17 | Strata Critical Medical, Inc. (BLDEW) Delisted | Exer (M) | +13,889 | $2.5K | EDGAR |
| 2023-03-01 | Strata Critical Medical, Inc. (BLDEW) Delisted | Exer (M) | +58,423 | $10.5K | EDGAR |
| 2023-01-12 | Strata Critical Medical, Inc. (BLDEW) Delisted | Sell (S) | −5,139 | -$17.9K | EDGAR |
| 2023-01-05 | Strata Critical Medical, Inc. (BLDEW) Delisted | Exer (M) | +16,693 | $3.0K | EDGAR |
| 2022-11-14 | Strata Critical Medical, Inc. (BLDEW) Delisted | Grant (A) | +931,791 | $0 | EDGAR |
| 2022-10-11 | Strata Critical Medical, Inc. (BLDEW) Delisted | Sell (S) | −4,366 | -$17.3K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.